| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Section of Applied Physiology, Division of Geriatrics and Gerontology, and Claude D. Pepper Older Americans Independence Center, and 2 Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
To determine whether strength-trained individuals with physiological concentric left ventricular (LV) hypertrophy exhibit enhanced inotropic responses to catecholamines, we studied 11 bodybuilders, aged 33.0 ± 2 (SE) yr old, and 10 sedentary healthy subjects, aged 31.3 ± 2.4 yr old, at baseline and during infusion of incremental doses of dobutamine after atropine. The bodybuilders had larger LV mass, posterior wall and septal wall thicknesses, and wall thickness-to-radius ratio, assessed with two-dimensional echocardiography, than did the sedentary subjects. There was a significant correlation between LV mass and lean body mass irrespective of training status. Baseline LV fractional shortening was similar in the two groups. There was a greater inotropic response to dobutamine in the strength-trained individuals, as evidenced by a steeper slope of the fractional shortening-end-systolic wall stress relationship with a higher y-axis intercept and by a shallower end-systolic wall stress-end systolic diameter relationship without changes in end-diastolic diameter. The heart rate response to dobutamine was attenuated in the strength-trained athletes. There was a significant correlation (r = 0.604, P < 0.05) between the inotropic sensitivity to dobutamine and LV mass normalized for lean body mass in the bodybuilders. The data suggest that concentric LV physiological hypertrophy in the resistance-trained individuals is associated with enhanced inotropic but not chronotropic responses to catecholamines.
inotropic sensitivity; cardiac function; physiological cardiac concentric hypertrophy
This article has been cited by other articles:
|
|
 |
|
  M. A. Williams, W. L. Haskell, P. A. Ades, E. A. Amsterdam, V. Bittner, B. A. Franklin, M. Gulanick, S. T. Laing, and K. J. Stewart Resistance Exercise in Individuals With and Without Cardiovascular Disease: 2007 Update: A Scientific Statement From the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism Circulation, July 31, 2007; 116(5): 572 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Scott, B. T. A. Esch, M. J. Haykowsky, S. Isserow, M. S. Koehle, B. G. Hughes, D. Zbogar, S. S. D. Bredin, D. C. McKenzie, and D. E. R. Warburton Sex differences in left ventricular function and beta-receptor responsiveness following prolonged strenuous exercise J Appl Physiol, February 1, 2007; 102(2): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B M Mayosi, A Kardos, C H Davies, F Gumedze, A Hovnanian, S Burge, and H Watkins Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure Heart, January 1, 2006; 92(1): 105 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Gates, K. P. George, and I. G. Campbell Concentric adaptation of the left ventricle in response to controlled upper body exercise training J Appl Physiol, February 1, 2003; 94(2): 549 - 554. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
